Preventive Health Program 'Prolamvano' to Continue with National Health Insurance Funding
The preventive health program 'Prolamvano' will continue its operations without interruption, with funding transitioning to the National Organization for Healthcare Services Provision (EOPYY) starting September 1, 2026. This shift follows the conclusion of its funding from the Recovery Fund. A legislative amendment submitted to Parliament ensures that citizens will continue to receive these preventive examinations free of charge, with zero out-of-pocket costs. The program aims to provide essential health screenings and early detection services to the public. The transition to EOPYY funding is expected to ensure the long-term sustainability of these vital public health initiatives. This move underscores a commitment to maintaining accessible healthcare services for all citizens. The specific details of the covered examinations and eligibility criteria remain consistent under the new funding model. The government's decision reflects a strategic prioritization of preventative care within the national health system.
The transition of the 'Prolamvano' program's funding from the Recovery Fund to EOPYY signifies a strategic shift towards integrating preventative healthcare into the permanent national health infrastructure. This move aims to ensure the program's long-term viability and accessibility, removing reliance on temporary stimulus packages. By guaranteeing zero out-of-pocket costs for citizens, the policy reinforces the principle of universal access to essential health services. This approach aligns with a broader public health objective of shifting focus from reactive treatment to proactive prevention, potentially reducing long-term healthcare burdens and improving population health outcomes. The sustainability of such initiatives will depend on robust budgetary allocation and effective program management within EOPYY.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.